Home > Insider Trading > Filing (0000950170-25-075259)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1828673	Hcw Biologics Inc.	HCWB	Pharmaceutical Preparations (2834)	825024477

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1866258	C Hing Wong	C/O Hcw Biologics Inc 2929 N. Commerce Parkway Miramar FL 33025	Chief Executive Officer	No	No	No	No

Transaction Summary

Purchased:	8,054 shares	Avg. Price: $7.45	Total Value: $60,002.30
Number of Shares After Transactions:	501,911 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-05-16	8,054	$7.45	501,911	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares were issued pursuant to a conversion of Unsecured Convertible Promissory Notes which were issued to six holders through a Company financing of an aggregate principal of $270,000 in one-year Notes. The Notes contained a mandatory conversion provision, which resulted in the Notes converting into shares of common stock at a mandatory conversion price of $7.45 per share as set by the registered offering. The Notes converted after the closing of the Company's registered offering on May 15, 2025. The conversion transaction also included an allocated portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.